Can you provide the average price target for INOGEN INC stock?
8 analysts have analysed INGN and the average price target is 13.26 USD. This implies a price increase of 120.45% is expected in the next year compared to the current price of 6.015.
NASDAQ:INGN • US45780L1044
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INOGEN INC (INGN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-06-16 | B. Riley Securities | Initiate | Buy |
| 2025-05-22 | Needham | Upgrade | Hold -> Buy |
| 2025-05-08 | Stifel | Maintains | Hold -> Hold |
| 2025-04-09 | Needham | Reiterate | Hold -> Hold |
| 2025-02-27 | Needham | Reiterate | Hold -> Hold |
| 2025-02-26 | Needham | Reiterate | Hold -> Hold |
| 2025-01-30 | Needham | Reiterate | Hold -> Hold |
| 2025-01-14 | Needham | Reiterate | Hold -> Hold |
| 2024-11-08 | Needham | Reiterate | Hold |
| 2024-08-07 | Needham | Reiterate | Hold |
| 2024-05-08 | Needham | Reiterate | Hold |
| 2024-05-08 | Stifel | Maintains | Hold -> Hold |
| 2024-04-09 | Needham | Reiterate | Hold |
| 2024-02-15 | William Blair | Upgrade | Market Perform -> Outperform |
| 2023-11-08 | JP Morgan | Maintains | Underweight -> Underweight |
| 2023-08-08 | Stifel | Maintains | Hold -> Hold |
| 2023-08-08 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2023-07-14 | Needham | Downgrade | Buy -> Hold |
| 2023-04-20 | Needham | Reiterate | Buy |
| 2023-02-28 | Needham | Reiterate | Buy |
| 2023-02-24 | Needham | Maintains | Buy |
| 2023-01-17 | William Blair | Downgrade | Outperform -> Market Perform |
| 2022-11-03 | JP Morgan | Maintains | Neutral |
| 2022-11-02 | Needham | Maintains | Buy |
| 2022-05-09 | Stifel | Maintains | Hold |
| 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|
| Revenue YoY % growth | 315.66M -16.31% | 335.705M 6.35% | 348.668M 3.86% | 376.28M 7.92% | 405.86M 7.86% | |
| EBITDA YoY % growth | -45.679M -381.34% | -17.728M 61.19% | -7.764M 56.20% | 6.885M 188.68% | 9.792M 42.22% | |
| EBIT YoY % growth | -63.831M -93.43% | -38.732M 39.32% | -28.423M 26.62% | -29.58M -4.07% | -22.185M 25.00% | |
| Operating Margin | -20.22% | -11.54% | -8.15% | -7.86% | -5.47% | |
| EPS YoY % growth | -2.99 -115.11% | -1.52 49.16% | -0.79 48.03% | -0.86 -8.65% | -0.59 31.49% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.29 -15.46% | -0.16 -5.40% | -0.14 -11.02% | -0.27 -4.55% | -0.24 18.37% | -0.10 36.13% | -0.07 50.88% | -0.19 31.71% |
| Revenue Q2Q % growth | 83.997M 2.09% | 99.195M 7.50% | 101.75M 10.13% | 91.392M 11.83% | 94.962M 13.05% | 105.47M 6.33% | 111.08M 9.17% | 103.22M 12.94% |
| EBITDA Q2Q % growth | -1.377M 44.18% | 2.244M -47.52% | 2.499M -75.72% | -969K -108.54% | 1.122M 181.48% | 2.754M 22.73% | 4.386M 75.51% | 4.386M 552.63% |
| EBIT Q2Q % growth | -9.384M -22.57% | -5.814M 5.14% | -5.457M -2.34% | -9.027M 3.00% | -6.426M 31.52% | -4.794M 17.54% | -3.162M 42.06% | -3.162M 64.97% |
All data in USD
8 analysts have analysed INGN and the average price target is 13.26 USD. This implies a price increase of 120.45% is expected in the next year compared to the current price of 6.015.
INOGEN INC (INGN) will report earnings on 2026-05-05, after the market close.
The consensus EPS estimate for the next earnings of INOGEN INC (INGN) is -0.29 USD and the consensus revenue estimate is 84.00M USD.
The consensus rating for INOGEN INC (INGN) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.